1. Stone, GW, Witzenbichler, B, Weisz, G, et al. Platelet reactivity and clinical outcomes after coronary artery implantation of drug-eluting stents (ADAPT-DES): A prospective multicentre registry study. Lancet 2013; 382: 614–623. DOI: 10.1016/S0140-6736(13)61170-8
Google Scholar | Crossref | Medline | ISI2. Price, MJ, Berger, PB, Teirstein, PS, et al. Standard- vs high-dose clopidogrel based on platelet function testing after percutaneous coronary intervention: the GRAVITAS randomized trial. JAMA 2011; 305: 1097–1105. DOI: 10.1001/jama.2011.290
Google Scholar | Crossref | Medline | ISI3. Mallouk, N, Labruyere, C, Reny, JL, et al. Prevalence of poor biological response to clopidogrel: A systematic review. Thromb Haemostasis 2012; 107: 494–506. DOI: 10.1160/TH11-03-0202
Google Scholar | Crossref | Medline | ISI4. Guirgis, M, Thompson, P, Jansen, S. Review of aspirin and clopidogrel resistance in peripheral arterial disease. J Vas Surg 2017; 66: 1576–1586. DOI: 10.1016/j.jvs.2017.07.065
Google Scholar | Crossref | Medline5. Spiliopoulos, S, Pastromas, G, Katsanos, K, et al. Platelet responsiveness to clopidogrel treatment after peripheral endovascular procedures: The PRECLOP study: Clinical impact and optimal cutoff value of on-treatment high platelet reactivity. J Am Coll Cardiol 2013; 61: 2428–2434. DOI: 10.1016/j.jacc.2013.03.036
Google Scholar | Crossref | Medline | ISI6. Eikelboom, JW, Hankey, GJ, Thom, J, et al. Enhanced antiplatelet effect of clopidogrel in patients whose platelets are least inhibited by aspirin: A randomized crossover trial. J Thromb Haemost 2005; 3: 2649–2655. DOI: 10.1111/j.1538-7836.2005.01640.x
Google Scholar | Crossref | Medline7. Gonzalez, A, Moniche, F, Cayuela, A, et al. Antiplatelet effects of clopidogrel dose adjustment (75 mg/d vs 150 mg/d) after carotid stenting. J Vas Sur 2014; 60: 428–435. DOI: 10.1016/j.jvs.2014.01.068
Google Scholar | Crossref | Medline8. Bernlochner, I, Jaitner, J, Fries, V, et al. High on-treatment platelet reactivity and outcomes after percutaneous endovascular procedures in patients with peripheral artery disease. Vasa 2016; 45: 155–161. DOI: 10.1024/0301-1526/a000510
Google Scholar | Crossref | Medline9. Ajadi, E, Kabir, S, Cook, A, et al. Predictive value of platelet reactivity unit (PRU) value for thrombotic and hemorrhagic events during flow diversion procedures: a meta-analysis. J Neurointerv Surg 2019; 11: 1123–1128. DOI: 10.1136/neurintsurg-2019-014765
Google Scholar | Crossref | Medline10. Sibbing, D, Aradi, D, Alexopoulos, D, et al. Updated expert consensus statement on platelet function and genetic testing for guiding P2Y12 receptor inhibitor treatment in percutaneous coronary intervention. JACC Cardiovasc Interv 2019; 12: 1521–1537. DOI: 10.1016/j.jcin.2019.03.034
Google Scholar | Crossref | Medline11. Geisler, T, Langer, H, Wydymus, M, et al. Low response to clopidogrel is associated with cardiovascular outcome after coronary stent implantation. Eur Heart J 2006; 27: 2420–2425. DOI: 10.1093/eurheartj/ehl275
Google Scholar | Crossref | Medline | ISI12. Wisman, PP, Roest, M, Asselbergs, FW, et al. Platelet-reactivity tests identify patients at risk of secondary cardiovascular events: A systematic review and meta-analysis. J Thromb Haemost 2014; 12: 736–747. DOI: 10.1111/jth.12538
Google Scholar | Crossref | Medline13. Freeman, PM, Moschonas, KE, Hinz, C, et al. Changes in platelet function independent of pharmacotherapy following coronary intervention in non-ST-elevation myocardial infarction patients. Atherosclerosis 2015; 243: 320–327. DOI: 10.1016/j.atherosclerosis.2015.09.024
Google Scholar | Crossref | Medline14. Montalescot, G, Sideris, G, Meuleman, C, et al. A randomized comparison of high clopidogrel loading doses in patients with non-ST-segment elevation acute coronary syndromes: the ALBION (Assessment of the Best Loading Dose of Clopidogrel to Blunt Platelet Activation, Inflammation and Ongoing Necrosis) trial. J Am Coll Cardiol 2006; 48: 931–938. DOI: 10.1016/j.jacc.2006.04.090
Google Scholar | Crossref | Medline | ISI15. Gurbel, PA, Bliden, KP, Hayes, KM, et al. The relation of dosing to clopidogrel responsiveness and the incidence of high post-treatment platelet aggregation in patients undergoing coronary stenting. J Am Coll Cardiol 2005; 45: 1392–1396. DOI: 10.1016/j.jacc.2005.01.030
Google Scholar | Crossref | Medline | ISI16. Brar, SS, ten Berg, J, Marcucci, R, et al. Impact of platelet reactivity on clinical outcomes after percutaneous coronary intervention. A collaborative meta-analysis of individual participant data. J Am Coll Cardiol 2011; 58: 1945–1954. DOI: 10.1016/j.jacc.2011.06.059
Google Scholar | Crossref | Medline | ISI